AI assistant
Sending…
Pulmonx Corp — Director's Dealing 2021
Apr 9, 2021
34428_dirs_2021-04-08_e437e50a-1515-4769-841a-96046d32c6f4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2020-09-30
Reporting Person: FERRARI RICHARD M (Director)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $2.20 | 2030-08-27 | Common Stock (6000) | Direct |
Footnotes
F1: The shares subject to the option vest in 12 equal monthly installments beginning on October 24, 2019.
More from Pulmonx Corp
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 4
Annual Report
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2025
Dec 11
Director's Dealing
2025
Dec 9
Regulatory Filings
2025
Dec 9
Director's Dealing
2025
Dec 4
Director's Dealing
2025
Dec 4